Navigation Links
Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference

Live Web Cast Scheduled for May 19 at 10:15 a.m. Eastern Time

VANCOUVER, May 16 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced that S. Wayne Kay, Chief Executive Officer, is scheduled to present at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Monday May 19th at 10:15 a.m. EDT.

A live web cast of the presentation will be available on the Company's Web site at bmenu=3 and replays will be available for 14 days starting approximately three hours after the initial presentation.

About Response Biomedical

Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP(R) Platform for clinical and environmental applications. RAMP(R) represents a new paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point-of-care testing and laboratory use. The RAMP(R) system consists of a Reader and single-use disposable test cartridges, and has the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories. RAMP(R) clinical tests are commercially available for the early detection of heart attack and congestive heart failure.

In late 2006, the Company formed a strategic alliance with 3M Company to commercialize rapid infectious disease tests. In the non-clinical market, RAMP(R) Tests are currently provided for the environmental detection of West Nile Virus, and Biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. Several other product applications are under development. Response has achieved CE Marking and its Quality Management System is registered to ISO 13485: 2003 and ISO 9001: 2000.

Response Biomedical is a publicly traded company, listed on the TSX under the trading symbol "RBM" and quoted on the OTC Bulletin Board under the symbol "RPBIF". For further information, please visit the Company's website at

CONTACT: Response Biomedical Contacts: Bill Wickson, Manager, Investor Relations, Response Biomedical Corporation, Tel (604) 456-6073, Email:; Brian Korb, Vice President, The Trout Group LLC, Tel: (646) 378-2923, Email:

SOURCE Response Biomedical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

2. Passport Health Disaster Response Experts Offer Services to Myanmar Volunteers
3. Study identifies molecular response of cartilage to injury
4. Aspen Institute to Release Presidential Candidates Responses to Health Care Reform Questionnaire; New Zogby Poll Findings Also to be Released
5. Previously unseen switch regulates breast cancer response to estrogen
6. CNS Response, Inc.: Poster Session on Referenced-EEG Guided Medication to Be Presented at the American Psychiatric Association 161st Annual Meeting
7. CNS Response, Inc. Names William E. Bunney, Jr., MD to Scientific Advisory Board
8. CNS Response, Inc: rEEG(R) Research to be Presented at 38th National Council Conference
9. Largest Ever Regional AIDS Conference to Review Epidemic Status and Changing Challenges in the Response
10. Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria
11. PCMA Response to New York Times Article on Biotech Medicine Costs
Post Your Comments:
(Date:11/24/2015)... ... 2015 , ... Eric C. Seidel, DMD and Stephanie DeFilippo, ... revolutionary BIOLASE WaterLase iPlus 2.0™ system. This advanced laser technology uses light energy ... dentist in Gettysburg, PA . From routine visits to cosmetic treatments, laser dentistry ...
(Date:11/24/2015)... ... , ... Charitable giving is at its peak during the holidays. In ... of the year totalling over $358 billion in 2014. With more than 1.5 ... those individuals who want to “give back” during the holidays. , “With so many ...
(Date:11/24/2015)... ... ... DMG Productions announced that they will feature Aphria, Inc., in an upcoming episode ... and show times TBA. , Aphria, Inc., is a publicly traded company incorporated under ... medical marijuana pursuant to the Marijuana for Medical Purposes Regulations (the “MMPR”). , Aphria ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the organization will waive paid entry and parking fees at several of their ... Monument Mountain in Great Barrington in support of REI’s Black Friday #OptOutside Campaign. ...
(Date:11/24/2015)... N.J. (PRWEB) , ... November 24, 2015 , ... ... will gather to share their knowledge and experiences at a live taping of ... the Ruesch Center for the Cure of Gastrointestinal Cancers 2015 Symposium at Georgetown ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 24, 2015 F1000Workspace ... for scientists - since it was launched just six months ... reference management and authoring platform for scientists - since it ... million references have been loaded on to F1000Workspace ... scientists - since it was launched just six months ago. ...
(Date:11/24/2015)... iRhythm Technologies, Inc. , a leading digital health care solutions company ... in the 27th Annual Piper Jaffray Healthcare Conference at The New ... . Kevin King , Chief Executive Officer of iRhythm, is ... --> --> About iRhythm ... . --> iRhythm is a privately held digital healthcare ...
(Date:11/24/2015)... The uptake of recently approved and pipeline premium ... of market growth to 2021, says GBI Research ... products for Type 1 Diabetes Mellitus (T1DM), will be a key driver ... . --> The uptake of recently approved and pipeline ... driver of market growth to 2021, says GBI Research ...
Breaking Medicine Technology: